PLAU and neoplasm: Moreover, by combining agents targeting the uPA system with nanobins, it is possible to target precisely tumor cells [161], deliver a larger amount of cytotoxic drugs in the tumor cells [162] and increase drug circulation half-life and specific cytotoxicity [163].